British health service faces paying higher prices for US drugs
Copy link
British health service faces paying higher prices for US drugs
British health service faces paying higher prices for US drugs
Copy link

Government prepares to boost spending on medicines to avoid a tariff hit

The US president has told GSK and AstraZeneca to ‘negotiate harder with foreign freeloading nations’

Drug prices in the UK could rise amid 100 per cent tariffs on branded medicines and pressure from US President Donald Trump to…

Ministers called on to protect drug supplies and NHS costs from transatlantic trade shock

Drugmaker echoes president’s insistence that overseas health services fund new treatments

‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments